You are here : Home > 80 Years of Science & Technology Shaping the Future

80 Years of Science & Technology Shaping the Future

From 12/1/2025 to 12/1/2025
The Embassy of France, Washington, DC


​​ trame-angle-gauche-535x340.png



Throughout the year 2025, the CEA, ranked among the world’s 100 innovation organization, will celebrate, along with its main foreign partners in Washington, Brussels and Osaka, its 80th anniversary, sharing with the public its major achievements, innovations and inspiring stories.

Join us on December 1st at the French Embassy in DC, to learn more about the CEA and its collaborations with many US academic and industrial partners in some of its major strategic areas of research and innovation. American and French experts will discuss current trends and prospects in the fields of nuclear energy, microelectronics, health and high-performance computing, and showcase the CEA’s great scientific discoveries and technological innovations that have improved daily lives of citizens.


Program

2:00 PM 

Welcome coffee and photo exhibition

2:30 PM

OPENING ADDRESS BY 
Mrs Anne-Isabelle Etienvre,
 Chairman of the CEA.

2:40 PM

​Fission and fusion
THE CONTRIBUTION OF R&D TO POWER THE WORLD WITH BULK, LOW CARBON AND SAFE ELECTRICITY 

This roundtable discussion will provide a cross-sectional view of nuclear research from both American and French perspectives, regarding both fission - from the first fission nuclear facilities to the water reactors and the innovative reactors like Na-fast reactors and molten salt reactors – and fusion.

Moderator: 
Introduction:
Philippe Stohr (CEA, Director of Energy Division) 
Panelists:

■  Patrick Blanc-Tranchant (CEA, Deputy Director of energy programs) 
■  Janelle Eddins (DOE)   TBC
■  Jérôme Bucalossi (CEA, Director of IRFM)  
■  Office of science (DOE) – TBC

3:30 PM

FROM TECHNOLOGY TO THERAPY
INNOVATION SHAPING THE FUTURE OF HEALTH

This session will shed the light on CEA-USA collaborations on the clinical translation of disruptive technology for neurological diseases and cancer. A work that is illustrated by the development and application of high-field MRI methodologies, new therapies for neurodevelopmental diseases, and the successful industrialization of innovative microtechnology for fast and reliable bioproduction and in-vitro diagnostic solutions.

Moderator: 
Introduction:
Romina Aron Badin (CEA, Director of MIRCen)
Speakers:

■ Kamil Ugurbil (Univ. of Minnesota, Director of the Center for Magnetic Resonance Research)
■ Barbara S. Stonestreet (Brown Univ. Professor of Pediatrics)
■ (MIT or) Selim Olcum (co-founder of Travera) – TBC

4:10 PM

Coffee break and photo exhibition

4:40 PM

NEXT GENERATION OF SEMICONDUCTORS
INNOVATION & INDUSTRY SYNERGY

US–FR Innovation & Industry Synergy (à developper)

Moderator: Charles Wessner (Center for Strategic and International Studies)
Introduction:Julie Galland (CEA, Director of Technology Research)
Speakers:

■  John Neuffer (SIA) – TBC
■ 
Dave Anderson (NY CREATES) – TBC
■ 
Sébastien Dauvé (CEA, Director of LETI)

5:20 PM

Exascale Frontiers
CEA and DOE Partnerships in HPC and Simulation

This session will present CEA-USA collaborations on high-performance computing and numerical simulation. From performance-portable programming models (Kokkos/CExA) to open-source ecosystems (HPSF) and scientific breakthroughs at scale (WarpX, Gordon Bell Prize), it will showcase how joint efforts are driving the exascale frontier.

Moderator: 

Introduction: Julien Bigot (Computer scientist at CEA)
Speakers:
■  Damien Lebrun-Grandie (Computational Scientist at ORNL)
■  Christian Trott (Computational Scientist at SNL)
    & Julien Bigot (CEA)
■  Jean-Luc Vay (UC Berkeley, Senior Scientist at LBNL) 

6:00 PM

ADDRESS BY 
H.E. Mr. Laurent Bili,
Ambassador of France to the United States.

6:10 PM

Cocktail reception

8:00 PM

End of the event


Venue and 
practical information

photo-ambassade-de-France-Washington.png

La Maison Française at the Embassy of France  

4101 Reservoir Road NW, Washington, DC, 20007 ​


ACCESS PLAN

​Your ID will be asked for security check upon your arrival.
This invitation is personal and should not be transferred.

The CEA: 80 years 
of research and innovation meeting 
the most pressing challenges

 © CEA
 

Nuclear, medicine, digital, space, defence, electronics, and more! Since its creation in 1945, the CEA has been behind many great scientific discoveries and technological innovations. These achievements have helped us to meet the challenges of the last eight decades and change millions’ daily lives forever.

At the crossroads of scientific knowledge, technology, markets, uses, industrial needs and public policies, the CEA has adopted a highly original approach. It relies on the alliance between science and technology, with a prominent scientific component, in cooperation with academic partners, in France, Europe and worldwide, and a capacity to respond to the innovation needs of industry.

This approach also benefits from multidisciplinarity and interdisciplinarity, with an ability to draw on, and combine, different areas of expertise, delivering breakthrough technologies and solutions, with a well-established experience of managing major projects, including research and technology infrastructures.


Several decades of cooperation between the CEA and American partners

 © X.Coppolani/CEA


In the field of nuclear energy, cooperation between the CEA and its US partners, among which the DOE and its National Laboratories, has been very active for several decades, covering both the areas of fission and fusion energy.

In nuclear fission, research work on reactor technologies and their nuclear fuel cycles greatly contributed to the wide expansion of nuclear energy as a clean, safe, bulk and affordable source of energy.

In the field of fusion, France hosts the international ITER project, and the CEA is one of its major scientific partners, namely with its WEST tokamak in operation nearby ITER.


The CEA is involved, alongside with its American partners, in cutting-edge research programs in the fields of high-energy physics, astrophysics, and HPC.

In elementary particle physics, the CEA is associated with the DOE in a proton accelerator project led by the Fermi National Accelerator Laboratory (Fermilab). In the space sector, the CEA is involved in the James Webb program developed by NASA in cooperation with the ESA.

© CEA/NASA



The CEA and the Lawrence Berkeley National Laboratory (LBNL) jointly won in 2022 the prestigious Gordon Bell Prize for their collaborative work in high-performance computing and numerical simulation applied to relativistic plasma dynamics.


© Jo Julia Ramsey/SC Photography


On microelectronics, existing collaborations pave the way for ambitious strategic partnerships.

In the field of microelectronics and nanotechnologies, the CEA has tied up with numerous American academic and institutional players such as Caltech, UC Berkeley, Stanford University, and NIST.


© Bruno Lavit / CEA - © Applied Materials.


Strategic industrial collaborations continue to be developed. They started in the 1980s with IBM, covering the dissemination of SOI (Silicon On Insulator) and advanced architectures for the next generation of AI computing, with partners such as GlobalFoundries and AMD. These collaborations also extend to the manufacture of equipment for semiconductor production, as illustrated by the announcement, in 2023, of the creation of a of a joint laboratory between the CEA and Applied Materials



On health technologies

The CEA has been involved in research on health-related technologies ever since its creation. Its goal today is to capitalize on all the expertise developed over the years to contribute to the emergence of the medicine of the future, in close association with clinical research partner organizations and hospitals. Based on cutting-edge fundamental research, it devises and develops smart medical technologies to provide new generations of therapies and move current medicine towards more predictive, personalized, preventive medicine where the patient plays an essential role in the care pathway. 




Practical information

Top page